Focus on BTK Inhibition
The Evolving Treatment Landscape of Follicular Lymphoma: Focus on BTK Inhibition

Released: April 10, 2024

Expiration: July 30, 2024

Christopher R. Flowers
Christopher R. Flowers, MD, MS

Activity

Progress
1
Course Completed

The Evolving Treatment Landscape of Follicular Lymphoma: Focus on BTK Inhibition

Key Takeaways:

  • Review the ROSEWOOD data for zanubrutinib in follicular lymphoma
  • Understand how zanubrutinib could fit within the broader follicular lymphoma treatment landscape